Biotech · Private company
I-Mab Biopharma US Limited
Track this companyFree. Adds I-Mab Biopharma US Limited to your Dealase workspace and tells you when its record changes.
Clinical trials92 recruiting or active
Pipeline programs19From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline19
- TJ003234Phase 3 · Coronavirus Disease 2019 COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- 5FluorouracilPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CapecitabinePhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- GivastomigPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- LeucovorinPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- OxaliplatinPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TJ004309Phase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TJ003234Phase 1 · Healthy Adult SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- TJ011133Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TJ033721 (givastomig)Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TJ033721 (givastomig) , nivolumab, chemotherapyPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TJ033721 (givastomig), chemotherapyPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TJ033721 (givastomig), durvalumab, chemotherapyPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TJ210001Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- AtezolizumabCancerClinicalTrials.gov · fetched Nov 12, 2026
- TJ004309CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)PHASE2 · RECRUITING · started Feb 11, 2026ClinicalTrials.gov NCT07432295 · fetched Nov 12, 2026
- Nasal Protollin in Early Symptomatic Alzheimer's DiseasePHASE1 · COMPLETED · started Nov 18, 2021ClinicalTrials.gov NCT07187141 · fetched Nov 12, 2026
- A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid TumorsPHASE2 · COMPLETED · started Nov 2, 2021ClinicalTrials.gov NCT05001347 · fetched Nov 12, 2026
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Jun 29, 2021ClinicalTrials.gov NCT04900818 · fetched Nov 12, 2026
- Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid TumorsPHASE1 · COMPLETED · started Dec 17, 2020ClinicalTrials.gov NCT04678921 · fetched Nov 12, 2026
- Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)PHASE2_PHASE3 · COMPLETED · started Apr 11, 2020ClinicalTrials.gov NCT04341116 · fetched Nov 12, 2026
- Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and LymphomaPHASE1 · COMPLETED · started Apr 16, 2019ClinicalTrials.gov NCT03934814 · fetched Nov 12, 2026
- Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult SubjectsPHASE1 · COMPLETED · started Mar 18, 2019ClinicalTrials.gov NCT03794180 · fetched Nov 12, 2026
- Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic CancerNO_LONGER_AVAILABLEClinicalTrials.gov NCT04869501 · fetched Nov 12, 2026